<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="521" height="256" viewBox="0 0 521 256"><rect width="521" height="256" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(50,12)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z" stroke-width="0"/><g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis titled 'Concentration (µg/mL)' for a log scale with values from 1e-4 to 1e+1"><g transform="translate(0.5,200.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,0)" x2="0" y2="4" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(120,0)" x2="0" y2="4" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(240,0)" x2="0" y2="4" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="middle" transform="translate(0,17)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1e-4</text><text text-anchor="middle" transform="translate(120,17)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1e-2</text><text text-anchor="middle" transform="translate(240,17)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1e+0</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="300" y2="0" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(150,36)" font-family="Helvetica" font-size="14px" font-weight="bold" fill="#000" opacity="1">Concentration (µg/mL)</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Fraction Infectivity' for a linear scale with values from 0.0 to 1.2"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,200)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,167)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,133)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,67)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,33)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-4" y2="0" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-6,204)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.0</text><text text-anchor="end" transform="translate(-6,170.66666666666666)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.2</text><text text-anchor="end" transform="translate(-6,137.33333333333331)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.4</text><text text-anchor="end" transform="translate(-6,104)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.6</text><text text-anchor="end" transform="translate(-6,70.66666666666666)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">0.8</text><text text-anchor="end" transform="translate(-6,37.33333333333333)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1.0</text><text text-anchor="end" transform="translate(-6,4)" font-family="Helvetica" font-size="14px" font-weight="normal" fill="#000" opacity="1">1.2</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,200)" x2="0" y2="-200" stroke="black" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-30.4619140625,100) rotate(-90) translate(0,-3)" font-family="Helvetica" font-size="14px" font-weight="bold" fill="#000" opacity="1">Fraction Infectivity</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-scope layer_0_pathgroup" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.99978892881; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.369L26.751,33.372L28.058,33.376L29.365,33.38L30.672,33.385L31.98,33.39L33.287,33.396L34.594,33.402L35.901,33.409L37.208,33.416L38.515,33.424L39.822,33.433L41.129,33.443L42.436,33.454L43.743,33.466L45.05,33.48L46.357,33.494L47.12,33.503L47.664,33.51L48.971,33.528L50.279,33.547L51.586,33.568L52.893,33.592L54.2,33.618L55.507,33.646L56.814,33.677L58.121,33.711L59.428,33.749L60.735,33.79L62.042,33.836L63.349,33.885L64.656,33.94L65.963,34.001L67.271,34.067L68.578,34.14L69.885,34.22L71.192,34.307L72.499,34.404L73.806,34.51L75.113,34.626L76.42,34.754L77.727,34.894L79.034,35.048L80.341,35.218L81.648,35.403L82.955,35.607L83.243,35.654L84.263,35.83L85.57,36.075L86.877,36.343L88.184,36.637L89.491,36.96L90.798,37.313L92.105,37.699L93.412,38.122L94.719,38.584L96.026,39.09L97.333,39.642L98.64,40.245L99.947,40.903L101.254,41.62L102.562,42.401L103.869,43.252L105.176,44.176L106.483,45.181L107.79,46.27L109.097,47.451L110.404,48.728L111.711,50.109L113.018,51.598L114.325,53.202L115.632,54.927L116.939,56.777L118.246,58.758L119.394,60.608L119.554,60.874L120.861,63.13L122.168,65.527L123.475,68.068L124.782,70.754L126.089,73.584L127.396,76.556L128.703,79.668L130.01,82.914L131.317,86.287L132.624,89.778L133.931,93.379L135.238,97.076L136.546,100.857L137.853,104.707L139.16,108.609L140.467,112.548L141.774,116.504L143.081,120.462L144.388,124.403L145.695,128.309L147.002,132.163L148.309,135.95L149.616,139.655L150.923,143.264L152.23,146.765L153.537,150.148L154.845,153.404L155.504,154.997L156.152,156.527L157.459,159.511L158.766,162.353L160.073,165.051L161.38,167.604L162.687,170.013L163.994,172.279L165.301,174.407L166.608,176.399L167.915,178.26L169.222,179.994L170.529,181.608L171.837,183.107L173.144,184.496L174.451,185.782L175.758,186.97L177.065,188.067L178.372,189.078L179.679,190.009L180.986,190.865L182.293,191.652L183.6,192.374L184.907,193.037L186.214,193.644L187.521,194.2L188.829,194.709L190.136,195.175L191.443,195.601L191.629,195.659L192.75,195.99L194.057,196.346L195.364,196.671L196.671,196.967L197.978,197.237L199.285,197.484L200.592,197.709L201.899,197.914L203.206,198.101L204.513,198.272L205.82,198.427L207.128,198.568L208.435,198.697L209.742,198.814L211.049,198.921L212.356,199.018L213.663,199.107L214.97,199.188L216.277,199.261L217.584,199.328L218.891,199.388L220.198,199.444L221.505,199.494L222.812,199.54L224.12,199.581L225.427,199.619L226.734,199.654L227.753,199.678L228.041,199.685L229.348,199.713L230.655,199.739L231.962,199.763L233.269,199.784L234.576,199.804L235.883,199.822L237.19,199.838L238.497,199.853L239.804,199.866L241.112,199.878L242.419,199.889L243.726,199.899L245.033,199.908L246.34,199.917L247.647,199.924L248.954,199.931L250.261,199.937L251.568,199.943L252.875,199.948L254.182,199.953L255.489,199.957L256.796,199.961L258.103,199.965L259.411,199.968L260.718,199.971L262.025,199.973L263.332,199.976L263.876,199.977L264.639,199.978L265.946,199.98L267.253,199.982L268.56,199.983L269.867,199.985L271.174,199.986L272.481,199.988L273.788,199.989L275.095,199.99L276.403,199.991L277.71,199.991L279.017,199.992L280.324,199.993L281.631,199.994L282.938,199.994L284.245,199.995L285.552,199.995" stroke="#ff9da7" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999487336219; Antibody: m102.4" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.419L26.751,33.428L28.058,33.438L29.365,33.448L30.672,33.46L31.98,33.474L33.287,33.488L34.594,33.504L35.901,33.522L37.208,33.542L38.515,33.563L39.822,33.587L41.129,33.614L42.436,33.643L43.743,33.675L45.05,33.711L46.357,33.75L47.12,33.775L47.664,33.793L48.971,33.841L50.279,33.894L51.586,33.952L52.893,34.016L54.2,34.087L55.507,34.165L56.814,34.251L58.121,34.346L59.428,34.451L60.735,34.567L62.042,34.694L63.349,34.835L64.656,34.99L65.963,35.16L67.271,35.349L68.578,35.556L69.885,35.784L71.192,36.035L72.499,36.312L73.806,36.616L75.113,36.951L76.42,37.319L77.727,37.723L79.034,38.167L80.341,38.655L81.648,39.19L82.955,39.777L83.243,39.913L84.263,40.42L85.57,41.124L86.877,41.894L88.184,42.736L89.491,43.655L90.798,44.657L92.105,45.75L93.412,46.938L94.719,48.229L96.026,49.629L97.333,51.146L98.64,52.786L99.947,54.555L101.254,56.46L102.562,58.506L103.869,60.698L105.176,63.042L106.483,65.54L107.79,68.194L109.097,71.006L110.404,73.974L111.711,77.098L113.018,80.371L114.325,83.789L115.632,87.343L116.939,91.024L118.246,94.818L119.394,98.231L119.554,98.712L120.861,102.69L122.168,106.735L123.475,110.827L124.782,114.949L126.089,119.078L127.396,123.196L128.703,127.282L130.01,131.317L131.317,135.282L132.624,139.16L133.931,142.936L135.238,146.596L136.546,150.128L137.853,153.522L139.16,156.771L140.467,159.869L141.774,162.811L143.081,165.596L144.388,168.224L145.695,170.696L147.002,173.014L148.309,175.181L149.616,177.203L150.923,179.085L152.23,180.832L153.537,182.45L154.845,183.947L155.504,184.658L156.152,185.329L157.459,186.602L158.766,187.774L160.073,188.851L161.38,189.839L162.687,190.744L163.994,191.574L165.301,192.332L166.608,193.026L167.915,193.659L169.222,194.237L170.529,194.764L171.837,195.244L173.144,195.681L174.451,196.079L175.758,196.441L177.065,196.77L178.372,197.07L179.679,197.342L180.986,197.589L182.293,197.814L183.6,198.018L184.907,198.203L186.214,198.371L187.521,198.523L188.829,198.661L190.136,198.787L191.443,198.901L191.629,198.916L192.75,199.004L194.057,199.097L195.364,199.182L196.671,199.259L197.978,199.329L199.285,199.392L200.592,199.449L201.899,199.501L203.206,199.548L204.513,199.59L205.82,199.629L207.128,199.664L208.435,199.696L209.742,199.724L211.049,199.75L212.356,199.774L213.663,199.795L214.97,199.814L216.277,199.832L217.584,199.848L218.891,199.862L220.198,199.875L221.505,199.887L222.812,199.898L224.12,199.907L225.427,199.916L226.734,199.924L227.753,199.93L228.041,199.931L229.348,199.938L230.655,199.943L231.962,199.949L233.269,199.954L234.576,199.958L235.883,199.962L237.19,199.966L238.497,199.969L239.804,199.972L241.112,199.974L242.419,199.977L243.726,199.979L245.033,199.981L246.34,199.983L247.647,199.984L248.954,199.986L250.261,199.987L251.568,199.988L252.875,199.99L254.182,199.991L255.489,199.991L256.796,199.992L258.103,199.993L259.411,199.994L260.718,199.994L262.025,199.995L263.332,199.995L263.876,199.995L264.639,199.996L265.946,199.996L267.253,199.996L268.56,199.997L269.867,199.997L271.174,199.997L272.481,199.998L273.788,199.998L275.095,199.998L276.403,199.998L277.71,199.998L279.017,199.999L280.324,199.999L281.631,199.999L282.938,199.999L284.245,199.999L285.552,199.999" stroke="#af7aa1" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999903545802; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.349L26.751,33.351L28.058,33.354L29.365,33.356L30.672,33.359L31.98,33.362L33.287,33.366L34.594,33.37L35.901,33.375L37.208,33.38L38.515,33.385L39.822,33.392L41.129,33.399L42.436,33.407L43.743,33.417L45.05,33.427L46.357,33.439L47.12,33.446L47.664,33.452L48.971,33.467L50.279,33.483L51.586,33.502L52.893,33.523L54.2,33.547L55.507,33.573L56.814,33.603L58.121,33.637L59.428,33.674L60.735,33.717L62.042,33.765L63.349,33.818L64.656,33.879L65.963,33.946L67.271,34.022L68.578,34.108L69.885,34.204L71.192,34.312L72.499,34.433L73.806,34.57L75.113,34.723L76.42,34.894L77.727,35.087L79.034,35.303L80.341,35.546L81.648,35.818L82.955,36.122L83.243,36.194L84.263,36.464L85.57,36.846L86.877,37.274L88.184,37.753L89.491,38.288L90.798,38.885L92.105,39.552L93.412,40.295L94.719,41.123L96.026,42.044L97.333,43.068L98.64,44.203L99.947,45.46L101.254,46.851L102.562,48.385L103.869,50.074L105.176,51.929L106.483,53.962L107.79,56.183L109.097,58.601L110.404,61.226L111.711,64.064L113.018,67.121L114.325,70.399L115.632,73.898L116.939,77.614L118.246,81.54L119.394,85.151L119.554,85.666L120.861,89.976L122.168,94.451L123.475,99.069L124.782,103.802L126.089,108.622L127.396,113.497L128.703,118.394L130.01,123.279L131.317,128.119L132.624,132.881L133.931,137.536L135.238,142.055L136.546,146.416L137.853,150.598L139.16,154.584L140.467,158.363L141.774,161.927L143.081,165.27L144.388,168.391L145.695,171.293L147.002,173.98L148.309,176.459L149.616,178.737L150.923,180.824L152.23,182.731L153.537,184.468L154.845,186.046L155.504,186.786L156.152,187.478L157.459,188.773L158.766,189.943L160.073,190.998L161.38,191.949L162.687,192.803L163.994,193.571L165.301,194.259L166.608,194.876L167.915,195.429L169.222,195.924L170.529,196.366L171.837,196.761L173.144,197.114L174.451,197.429L175.758,197.711L177.065,197.961L178.372,198.185L179.679,198.384L180.986,198.562L182.293,198.72L183.6,198.861L184.907,198.987L186.214,199.099L187.521,199.198L188.829,199.287L190.136,199.366L191.443,199.436L191.629,199.445L192.75,199.498L194.057,199.554L195.364,199.603L196.671,199.647L197.978,199.686L199.285,199.721L200.592,199.752L201.899,199.779L203.206,199.804L204.513,199.825L205.82,199.845L207.128,199.862L208.435,199.877L209.742,199.891L211.049,199.903L212.356,199.914L213.663,199.923L214.97,199.932L216.277,199.939L217.584,199.946L218.891,199.952L220.198,199.957L221.505,199.962L222.812,199.966L224.12,199.97L225.427,199.973L226.734,199.976L227.753,199.978L228.041,199.979L229.348,199.981L230.655,199.983L231.962,199.985L233.269,199.987L234.576,199.988L235.883,199.99L237.19,199.991L238.497,199.992L239.804,199.993L241.112,199.994L242.419,199.994L243.726,199.995L245.033,199.995L246.34,199.996L247.647,199.996L248.954,199.997L250.261,199.997L251.568,199.997L252.875,199.998L254.182,199.998L255.489,199.998L256.796,199.998L258.103,199.999L259.411,199.999L260.718,199.999L262.025,199.999L263.332,199.999L263.876,199.999L264.639,199.999L265.946,199.999L267.253,199.999L268.56,199.999L269.867,200L271.174,200L272.481,200L273.788,200L275.095,200L276.403,200L277.71,200L279.017,200L280.324,200L281.631,200L282.938,200L284.245,200L285.552,200" stroke="#59a14f" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999961502991; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.34L26.751,33.34L28.058,33.341L29.365,33.342L30.672,33.342L31.98,33.343L33.287,33.344L34.594,33.345L35.901,33.346L37.208,33.347L38.515,33.348L39.822,33.349L41.129,33.35L42.436,33.352L43.743,33.353L45.05,33.355L46.357,33.357L47.12,33.358L47.664,33.359L48.971,33.361L50.279,33.363L51.586,33.366L52.893,33.369L54.2,33.372L55.507,33.375L56.814,33.378L58.121,33.382L59.428,33.386L60.735,33.391L62.042,33.395L63.349,33.401L64.656,33.406L65.963,33.413L67.271,33.419L68.578,33.426L69.885,33.434L71.192,33.443L72.499,33.452L73.806,33.462L75.113,33.473L76.42,33.485L77.727,33.498L79.034,33.511L80.341,33.526L81.648,33.543L82.955,33.56L83.243,33.564L84.263,33.579L85.57,33.6L86.877,33.623L88.184,33.647L89.491,33.674L90.798,33.702L92.105,33.733L93.412,33.767L94.719,33.804L96.026,33.843L97.333,33.886L98.64,33.933L99.947,33.983L101.254,34.038L102.562,34.097L103.869,34.161L105.176,34.23L106.483,34.306L107.79,34.387L109.097,34.476L110.404,34.572L111.711,34.675L113.018,34.788L114.325,34.909L115.632,35.041L116.939,35.184L118.246,35.338L119.394,35.484L119.554,35.505L120.861,35.686L122.168,35.882L123.475,36.093L124.782,36.322L126.089,36.57L127.396,36.837L128.703,37.127L130.01,37.439L131.317,37.777L132.624,38.141L133.931,38.534L135.238,38.959L136.546,39.417L137.853,39.91L139.16,40.442L140.467,41.015L141.774,41.631L143.081,42.294L144.388,43.007L145.695,43.773L147.002,44.595L148.309,45.477L149.616,46.422L150.923,47.433L152.23,48.516L153.537,49.672L154.845,50.907L155.504,51.56L156.152,52.223L157.459,53.624L158.766,55.114L160.073,56.695L161.38,58.372L162.687,60.146L163.994,62.021L165.301,63.998L166.608,66.079L167.915,68.265L169.222,70.556L170.529,72.952L171.837,75.453L173.144,78.056L174.451,80.758L175.758,83.556L177.065,86.446L178.372,89.422L179.679,92.478L180.986,95.607L182.293,98.8L183.6,102.05L184.907,105.346L186.214,108.678L187.521,112.037L188.829,115.41L190.136,118.788L191.443,122.159L191.629,122.638L192.75,125.511L194.057,128.835L195.364,132.12L196.671,135.356L197.978,138.534L199.285,141.645L200.592,144.681L201.899,147.636L203.206,150.503L204.513,153.277L205.82,155.954L207.128,158.531L208.435,161.004L209.742,163.374L211.049,165.638L212.356,167.797L213.663,169.851L214.97,171.802L216.277,173.651L217.584,175.4L218.891,177.052L220.198,178.61L221.505,180.077L222.812,181.456L224.12,182.75L225.427,183.964L226.734,185.102L227.753,185.937L228.041,186.166L229.348,187.16L230.655,188.088L231.962,188.955L233.269,189.762L234.576,190.514L235.883,191.214L237.19,191.865L238.497,192.47L239.804,193.031L241.112,193.553L242.419,194.037L243.726,194.486L245.033,194.903L246.34,195.288L247.647,195.646L248.954,195.977L250.261,196.283L251.568,196.566L252.875,196.829L254.182,197.071L255.489,197.296L256.796,197.503L258.103,197.695L259.411,197.872L260.718,198.036L262.025,198.187L263.332,198.327L263.876,198.382L264.639,198.456L265.946,198.575L267.253,198.685L268.56,198.787L269.867,198.881L271.174,198.967L272.481,199.047L273.788,199.121L275.095,199.189L276.403,199.252L277.71,199.31L279.017,199.364L280.324,199.413L281.631,199.459L282.938,199.501L284.245,199.539L285.552,199.575" stroke="#edc949" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999989799834; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.335L26.751,33.335L28.058,33.335L29.365,33.336L30.672,33.336L31.98,33.336L33.287,33.337L34.594,33.337L35.901,33.337L37.208,33.338L38.515,33.338L39.822,33.339L41.129,33.339L42.436,33.34L43.743,33.341L45.05,33.341L46.357,33.342L47.12,33.343L47.664,33.343L48.971,33.344L50.279,33.346L51.586,33.347L52.893,33.349L54.2,33.35L55.507,33.352L56.814,33.354L58.121,33.356L59.428,33.359L60.735,33.362L62.042,33.365L63.349,33.368L64.656,33.372L65.963,33.376L67.271,33.381L68.578,33.386L69.885,33.392L71.192,33.399L72.499,33.406L73.806,33.414L75.113,33.423L76.42,33.433L77.727,33.444L79.034,33.456L80.341,33.469L81.648,33.484L82.955,33.501L83.243,33.505L84.263,33.519L85.57,33.539L86.877,33.562L88.184,33.587L89.491,33.615L90.798,33.646L92.105,33.68L93.412,33.718L94.719,33.761L96.026,33.807L97.333,33.859L98.64,33.917L99.947,33.981L101.254,34.052L102.562,34.131L103.869,34.218L105.176,34.315L106.483,34.422L107.79,34.541L109.097,34.672L110.404,34.818L111.711,34.98L113.018,35.159L114.325,35.357L115.632,35.577L116.939,35.82L118.246,36.089L119.394,36.348L119.554,36.386L120.861,36.715L122.168,37.078L123.475,37.48L124.782,37.923L126.089,38.413L127.396,38.953L128.703,39.547L130.01,40.203L131.317,40.924L132.624,41.716L133.931,42.587L135.238,43.542L136.546,44.589L137.853,45.734L139.16,46.986L140.467,48.352L141.774,49.84L143.081,51.458L144.388,53.214L145.695,55.114L147.002,57.167L148.309,59.378L149.616,61.754L150.923,64.298L152.23,67.015L153.537,69.906L154.845,72.971L155.504,74.583L156.152,76.209L157.459,79.614L158.766,83.181L160.073,86.901L161.38,90.762L162.687,94.75L163.994,98.849L165.301,103.04L166.608,107.303L167.915,111.617L169.222,115.958L170.529,120.302L171.837,124.627L173.144,128.909L174.451,133.126L175.758,137.258L177.065,141.284L178.372,145.188L179.679,148.955L180.986,152.573L182.293,156.032L183.6,159.325L184.907,162.446L186.214,165.394L187.521,168.168L188.829,170.768L190.136,173.199L191.443,175.463L191.629,175.773L192.75,177.567L194.057,179.516L195.364,181.318L196.671,182.98L197.978,184.509L199.285,185.914L200.592,187.203L201.899,188.382L203.206,189.46L204.513,190.445L205.82,191.342L207.128,192.159L208.435,192.903L209.742,193.579L211.049,194.193L212.356,194.75L213.663,195.256L214.97,195.713L216.277,196.128L217.584,196.504L218.891,196.844L220.198,197.151L221.505,197.429L222.812,197.68L224.12,197.907L225.427,198.112L226.734,198.297L227.753,198.429L228.041,198.464L229.348,198.615L230.655,198.751L231.962,198.874L233.269,198.985L234.576,199.085L235.883,199.175L237.19,199.257L238.497,199.33L239.804,199.396L241.112,199.456L242.419,199.509L243.726,199.558L245.033,199.602L246.34,199.641L247.647,199.677L248.954,199.709L250.261,199.737L251.568,199.763L252.875,199.787L254.182,199.808L255.489,199.827L256.796,199.844L258.103,199.859L259.411,199.873L260.718,199.886L262.025,199.897L263.332,199.907L263.876,199.911L264.639,199.917L265.946,199.925L267.253,199.932L268.56,199.939L269.867,199.945L271.174,199.95L272.481,199.955L273.788,199.96L275.095,199.964L276.403,199.967L277.71,199.971L279.017,199.974L280.324,199.976L281.631,199.978L282.938,199.981L284.245,199.983L285.552,199.984" stroke="#e15759" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999998312932; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.334L26.751,33.334L28.058,33.334L29.365,33.334L30.672,33.334L31.98,33.334L33.287,33.334L34.594,33.334L35.901,33.334L37.208,33.335L38.515,33.335L39.822,33.335L41.129,33.336L42.436,33.336L43.743,33.337L45.05,33.337L46.357,33.338L47.12,33.339L47.664,33.339L48.971,33.34L50.279,33.341L51.586,33.343L52.893,33.345L54.2,33.347L55.507,33.35L56.814,33.353L58.121,33.356L59.428,33.361L60.735,33.366L62.042,33.372L63.349,33.38L64.656,33.389L65.963,33.4L67.271,33.412L68.578,33.427L69.885,33.446L71.192,33.467L72.499,33.493L73.806,33.524L75.113,33.56L76.42,33.604L77.727,33.656L79.034,33.718L80.341,33.792L81.648,33.88L82.955,33.985L83.243,34.011L84.263,34.11L85.57,34.259L86.877,34.436L88.184,34.646L89.491,34.897L90.798,35.195L92.105,35.549L93.412,35.969L94.719,36.467L96.026,37.057L97.333,37.755L98.64,38.58L99.947,39.554L101.254,40.699L102.562,42.044L103.869,43.619L105.176,45.456L106.483,47.592L107.79,50.063L109.097,52.907L110.404,56.162L111.711,59.86L113.018,64.029L114.325,68.688L115.632,73.844L116.939,79.487L118.246,85.591L119.394,91.291L119.554,92.109L120.861,98.972L122.168,106.097L123.475,113.383L124.782,120.719L126.089,127.992L127.396,135.094L128.703,141.925L130.01,148.402L131.317,154.46L132.624,160.053L133.931,165.157L135.238,169.764L136.546,173.883L137.853,177.533L139.16,180.743L140.467,183.546L141.774,185.981L143.081,188.083L144.388,189.892L145.695,191.441L147.002,192.763L148.309,193.889L149.616,194.846L150.923,195.657L152.23,196.343L153.537,196.923L154.845,197.412L155.504,197.629L156.152,197.825L157.459,198.172L158.766,198.465L160.073,198.711L161.38,198.918L162.687,199.092L163.994,199.238L165.301,199.36L166.608,199.463L167.915,199.55L169.222,199.622L170.529,199.683L171.837,199.734L173.144,199.777L174.451,199.813L175.758,199.843L177.065,199.869L178.372,199.89L179.679,199.908L180.986,199.923L182.293,199.935L183.6,199.946L184.907,199.954L186.214,199.962L187.521,199.968L188.829,199.973L190.136,199.977L191.443,199.981L191.629,199.982L192.75,199.984L194.057,199.987L195.364,199.989L196.671,199.991L197.978,199.992L199.285,199.993L200.592,199.994L201.899,199.995L203.206,199.996L204.513,199.997L205.82,199.997L207.128,199.998L208.435,199.998L209.742,199.998L211.049,199.999L212.356,199.999L213.663,199.999L214.97,199.999L216.277,199.999L217.584,199.999L218.891,200L220.198,200L221.505,200L222.812,200L224.12,200L225.427,200L226.734,200L227.753,200L228.041,200L229.348,200L230.655,200L231.962,200L233.269,200L234.576,200L235.883,200L237.19,200L238.497,200L239.804,200L241.112,200L242.419,200L243.726,200L245.033,200L246.34,200L247.647,200L248.954,200L250.261,200L251.568,200L252.875,200L254.182,200L255.489,200L256.796,200L258.103,200L259.411,200L260.718,200L262.025,200L263.332,200L263.876,200L264.639,200L265.946,200L267.253,200L268.56,200L269.867,200L271.174,200L272.481,200L273.788,200L275.095,200L276.403,200L277.71,200L279.017,200L280.324,200L281.631,200L282.938,200L284.245,200L285.552,200" stroke="#76b7b2" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999994187826; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.334L26.751,33.334L28.058,33.335L29.365,33.335L30.672,33.335L31.98,33.335L33.287,33.335L34.594,33.335L35.901,33.336L37.208,33.336L38.515,33.336L39.822,33.337L41.129,33.337L42.436,33.338L43.743,33.338L45.05,33.339L46.357,33.339L47.12,33.34L47.664,33.34L48.971,33.341L50.279,33.342L51.586,33.343L52.893,33.344L54.2,33.345L55.507,33.347L56.814,33.348L58.121,33.35L59.428,33.352L60.735,33.354L62.042,33.357L63.349,33.36L64.656,33.363L65.963,33.366L67.271,33.371L68.578,33.375L69.885,33.38L71.192,33.386L72.499,33.392L73.806,33.399L75.113,33.407L76.42,33.416L77.727,33.426L79.034,33.437L80.341,33.449L81.648,33.463L82.955,33.479L83.243,33.483L84.263,33.497L85.57,33.516L86.877,33.539L88.184,33.563L89.491,33.591L90.798,33.622L92.105,33.657L93.412,33.696L94.719,33.74L96.026,33.788L97.333,33.843L98.64,33.905L99.947,33.973L101.254,34.05L102.562,34.136L103.869,34.233L105.176,34.341L106.483,34.462L107.79,34.597L109.097,34.748L110.404,34.917L111.711,35.106L113.018,35.318L114.325,35.554L115.632,35.818L116.939,36.113L118.246,36.443L119.394,36.763L119.554,36.81L120.861,37.22L122.168,37.677L123.475,38.186L124.782,38.753L126.089,39.384L127.396,40.085L128.703,40.863L130.01,41.726L131.317,42.683L132.624,43.741L133.931,44.911L135.238,46.2L136.546,47.621L137.853,49.182L139.16,50.893L140.467,52.766L141.774,54.81L143.081,57.034L144.388,59.448L145.695,62.057L147.002,64.869L148.309,67.887L149.616,71.113L150.923,74.546L152.23,78.183L153.537,82.016L154.845,86.035L155.504,88.129L156.152,90.226L157.459,94.571L158.766,99.05L160.073,103.637L161.38,108.307L162.687,113.03L163.994,117.777L165.301,122.517L166.608,127.219L167.915,131.853L169.222,136.393L170.529,140.812L171.837,145.087L173.144,149.199L174.451,153.133L175.758,156.876L177.065,160.418L178.372,163.755L179.679,166.883L180.986,169.805L182.293,172.521L183.6,175.038L184.907,177.362L186.214,179.501L187.521,181.463L188.829,183.26L190.136,184.9L191.443,186.394L191.629,186.595L192.75,187.752L194.057,188.984L195.364,190.1L196.671,191.11L197.978,192.022L199.285,192.844L200.592,193.585L201.899,194.253L203.206,194.853L204.513,195.392L205.82,195.876L207.128,196.31L208.435,196.7L209.742,197.049L211.049,197.362L212.356,197.642L213.663,197.893L214.97,198.117L216.277,198.318L217.584,198.498L218.891,198.658L220.198,198.802L221.505,198.93L222.812,199.045L224.12,199.147L225.427,199.238L226.734,199.32L227.753,199.378L228.041,199.393L229.348,199.458L230.655,199.516L231.962,199.568L233.269,199.615L234.576,199.656L235.883,199.693L237.19,199.726L238.497,199.756L239.804,199.782L241.112,199.805L242.419,199.826L243.726,199.845L245.033,199.862L246.34,199.877L247.647,199.89L248.954,199.902L250.261,199.912L251.568,199.922L252.875,199.93L254.182,199.938L255.489,199.944L256.796,199.95L258.103,199.956L259.411,199.961L260.718,199.965L262.025,199.969L263.332,199.972L263.876,199.973L264.639,199.975L265.946,199.978L267.253,199.98L268.56,199.982L269.867,199.984L271.174,199.986L272.481,199.987L273.788,199.989L275.095,199.99L276.403,199.991L277.71,199.992L279.017,199.993L280.324,199.994L281.631,199.994L282.938,199.995L284.245,199.995L285.552,199.996" stroke="#4e79a7" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h300v200h-300Z"/><g><g class="mark-line role-mark layer_0_marks" role="graphics-object" aria-roledescription="line mark container"><path aria-label="Concentration (µg/mL): 3e-4; Fraction Infectivity: 0.999991903952; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="line mark" d="M25.444,33.335L26.751,33.335L28.058,33.335L29.365,33.335L30.672,33.335L31.98,33.336L33.287,33.336L34.594,33.336L35.901,33.336L37.208,33.337L38.515,33.337L39.822,33.337L41.129,33.338L42.436,33.338L43.743,33.339L45.05,33.339L46.357,33.34L47.12,33.34L47.664,33.34L48.971,33.341L50.279,33.342L51.586,33.343L52.893,33.344L54.2,33.345L55.507,33.346L56.814,33.347L58.121,33.348L59.428,33.35L60.735,33.352L62.042,33.354L63.349,33.356L64.656,33.358L65.963,33.36L67.271,33.363L68.578,33.366L69.885,33.369L71.192,33.373L72.499,33.377L73.806,33.381L75.113,33.386L76.42,33.392L77.727,33.398L79.034,33.404L80.341,33.411L81.648,33.419L82.955,33.428L83.243,33.43L84.263,33.437L85.57,33.448L86.877,33.46L88.184,33.472L89.491,33.487L90.798,33.502L92.105,33.519L93.412,33.538L94.719,33.559L96.026,33.581L97.333,33.607L98.64,33.634L99.947,33.665L101.254,33.698L102.562,33.735L103.869,33.776L105.176,33.821L106.483,33.87L107.79,33.924L109.097,33.984L110.404,34.049L111.711,34.122L113.018,34.201L114.325,34.289L115.632,34.385L116.939,34.491L118.246,34.607L119.394,34.719L119.554,34.735L120.861,34.876L122.168,35.031L123.475,35.201L124.782,35.388L126.089,35.594L127.396,35.82L128.703,36.068L130.01,36.34L131.317,36.639L132.624,36.967L133.931,37.327L135.238,37.721L136.546,38.153L137.853,38.626L139.16,39.144L140.467,39.711L141.774,40.331L143.081,41.008L144.388,41.747L145.695,42.553L147.002,43.431L148.309,44.387L149.616,45.427L150.923,46.556L152.23,47.78L153.537,49.107L154.845,50.541L155.504,51.308L156.152,52.09L157.459,53.759L158.766,55.554L160.073,57.481L161.38,59.545L162.687,61.749L163.994,64.099L165.301,66.596L166.608,69.243L167.915,72.039L169.222,74.983L170.529,78.073L171.837,81.304L173.144,84.67L174.451,88.164L175.758,91.774L177.065,95.49L178.372,99.299L179.679,103.185L180.986,107.132L182.293,111.123L183.6,115.139L184.907,119.163L186.214,123.175L187.521,127.157L188.829,131.091L190.136,134.96L191.443,138.747L191.629,139.28L192.75,142.439L194.057,146.022L195.364,149.486L196.671,152.82L197.978,156.018L199.285,159.073L200.592,161.982L201.899,164.742L203.206,167.352L204.513,169.814L205.82,172.128L207.128,174.299L208.435,176.329L209.742,178.224L211.049,179.988L212.356,181.627L213.663,183.148L214.97,184.556L216.277,185.857L217.584,187.058L218.891,188.165L220.198,189.184L221.505,190.121L222.812,190.981L224.12,191.771L225.427,192.494L226.734,193.157L227.753,193.634L228.041,193.763L229.348,194.318L230.655,194.825L231.962,195.288L233.269,195.711L234.576,196.096L235.883,196.448L237.19,196.769L238.497,197.061L239.804,197.327L241.112,197.57L242.419,197.791L243.726,197.992L245.033,198.174L246.34,198.341L247.647,198.492L248.954,198.63L250.261,198.755L251.568,198.869L252.875,198.972L254.182,199.067L255.489,199.152L256.796,199.23L258.103,199.3L259.411,199.365L260.718,199.423L262.025,199.476L263.332,199.524L263.876,199.543L264.639,199.568L265.946,199.607L267.253,199.643L268.56,199.676L269.867,199.706L271.174,199.733L272.481,199.758L273.788,199.78L275.095,199.8L276.403,199.818L277.71,199.835L279.017,199.85L280.324,199.864L281.631,199.877L282.938,199.888L284.245,199.898L285.552,199.908" stroke="#f28e2c" stroke-width="1.5"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g><g class="mark-symbol role-mark layer_1_marks" role="graphics-object" aria-roledescription="symbol mark container"><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 0.922; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,46.333333333333336)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 0.9571; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,40.48333333333331)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.83905; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,60.15833333333334)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.2739; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,154.35000000000002)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.00025; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,199.95833333333331)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: nAH1.3" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#ff9da7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 0.93595; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,44.00833333333332)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 0.88365; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,52.72499999999998)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.6371; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,93.81666666666666)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.0538; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,191.03333333333333)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.00295; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,199.50833333333333)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.00045; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,199.925)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: m102.4" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#af7aa1" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 0.98265; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,36.224999999999994)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 0.91335; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,47.77499999999999)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.70015; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,83.30833333333332)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.0632; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,189.46666666666667)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: HENV-26" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#59a14f" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.00705; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,32.15833333333333)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.02475; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,29.208333333333325)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.0155; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,30.75000000000001)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.88145; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,53.09166666666667)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.4662; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,122.29999999999998)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.0849; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,185.85)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0.00455; Antibody: HENV-32" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,199.24166666666667)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#edc949" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.1104; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,14.933333333333309)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.02955; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,28.408333333333324)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.0765; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,20.583333333333332)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.73365; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,77.725)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.16005; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,173.325)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.006; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,199)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0.0009; Antibody: HENV-103" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,199.85)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#e15759" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.05235; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,24.6083333333333)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.0248; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,29.200000000000003)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 0.6512; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,91.46666666666665)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.0228; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,196.2)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: HENV-117" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#76b7b2" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.0745; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,20.91666666666665)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.15255; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,7.908333333333339)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.03125; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,28.125)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.6598; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,90.03333333333335)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.0986; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,183.56666666666666)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.0016; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,199.73333333333335)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0; Antibody: EFNB2-monomeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,200)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#4e79a7" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-4; Fraction Infectivity: 1.0811; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(47.119790100646,19.816666666666638)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-3; Fraction Infectivity: 1.11225; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(83.24338958032376,14.625)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 1e-2; Fraction Infectivity: 1.10965; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(119.39367382312639,15.05833333333333)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 4e-2; Fraction Infectivity: 0.857; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(155.50393433711014,57.16666666666666)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 2e-1; Fraction Infectivity: 0.3797; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(191.62920156096675,136.71666666666667)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 6e-1; Fraction Infectivity: 0.00515; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(227.75280104064453,199.14166666666665)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/><path aria-label="Concentration (µg/mL): 3e+0; Fraction Infectivity: 0.0002; Antibody: EFNB3-dimeric" role="graphics-symbol" aria-roledescription="circle" transform="translate(263.87640052032225,199.96666666666667)" d="M3.162,0A3.162,3.162,0,1,1,-3.162,0A3.162,3.162,0,1,1,3.162,0" fill="#f28e2c" stroke-width="2" opacity="1"/></g><g class="mark-rule role-mark layer_2_marks" role="graphics-object" aria-roledescription="rule mark container"><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.8966; upper_lower: 0.9474; serum: nAH1.3; upper: 0.9474; lower: 0.8966" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,50.56666666666669)" x2="0" y2="-8.466666666666711" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.935; upper_lower: 0.9792; serum: nAH1.3; upper: 0.9792; lower: 0.935" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,44.16666666666664)" x2="0" y2="-7.366666666666632" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.7908; upper_lower: 0.8873; serum: nAH1.3; upper: 0.8873; lower: 0.7908" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,68.19999999999999)" x2="0" y2="-16.083333333333336" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.2105; upper_lower: 0.3373; serum: nAH1.3; upper: 0.3373; lower: 0.2105" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,164.91666666666666)" x2="0" y2="-21.133333333333326" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0; upper_lower: 0.0005; serum: nAH1.3; upper: 0.0005; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,200)" x2="0" y2="-0.08333333333331439" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0; upper_lower: 0; serum: nAH1.3; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,200)" x2="0" y2="0" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; serum: nAH1.3; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#ff9da7" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.8997; upper_lower: 0.9722; serum: m102.4; upper: 0.9722; lower: 0.8997" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,50.05)" x2="0" y2="-12.083333333333336" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.8744; upper_lower: 0.8929; serum: m102.4; upper: 0.8929; lower: 0.8744" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,54.266666666666666)" x2="0" y2="-3.08333333333335" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.6145; upper_lower: 0.6597; serum: m102.4; upper: 0.6597; lower: 0.6145" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,97.58333333333331)" x2="0" y2="-7.533333333333303" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.0419; upper_lower: 0.0657; serum: m102.4; upper: 0.0657; lower: 0.0419" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,193.01666666666665)" x2="0" y2="-3.96666666666664" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.0023; upper_lower: 0.0036; serum: m102.4; upper: 0.0036; lower: 0.0023" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,199.61666666666667)" x2="0" y2="-0.21666666666666856" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0003; upper_lower: 0.0006; serum: m102.4; upper: 0.0006; lower: 0.0003" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.95000000000002)" x2="0" y2="-0.05000000000001137" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; serum: m102.4; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#af7aa1" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.9752; upper_lower: 0.9901; serum: HENV-26; upper: 0.9901; lower: 0.9752" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,37.46666666666665)" x2="0" y2="-2.483333333333327" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.902; upper_lower: 0.9247; serum: HENV-26; upper: 0.9247; lower: 0.902" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,49.66666666666666)" x2="0" y2="-3.7833333333333172" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.6741; upper_lower: 0.7262; serum: HENV-26; upper: 0.7262; lower: 0.6741" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,87.64999999999998)" x2="0" y2="-8.683333333333323" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.0514; upper_lower: 0.075; serum: HENV-26; upper: 0.075; lower: 0.0514" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,191.4333333333333)" x2="0" y2="-3.9333333333333087" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0; upper_lower: 0; serum: HENV-26; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,200)" x2="0" y2="0" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0; upper_lower: 0; serum: HENV-26; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,200)" x2="0" y2="0" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; serum: HENV-26; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#59a14f" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 0.9851; upper_lower: 1.029; serum: HENV-32; upper: 1.029; lower: 0.9851" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,35.81666666666668)" x2="0" y2="-7.316666666666663" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.0211; upper_lower: 1.0284; serum: HENV-32; upper: 1.0284; lower: 1.0211" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,29.81666666666667)" x2="0" y2="-1.2166666666667112" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.0061; upper_lower: 1.0249; serum: HENV-32; upper: 1.0249; lower: 1.0061" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,32.316666666666706)" x2="0" y2="-3.1333333333333684" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.8754; upper_lower: 0.8875; serum: HENV-32; upper: 0.8875; lower: 0.8754" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,54.099999999999994)" x2="0" y2="-2.0166666666666657" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.457; upper_lower: 0.4754; serum: HENV-32; upper: 0.4754; lower: 0.457" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,123.83333333333333)" x2="0" y2="-3.066666666666663" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0832; upper_lower: 0.0866; serum: HENV-32; upper: 0.0866; lower: 0.0832" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,186.13333333333333)" x2="0" y2="-0.5666666666666629" stroke="#edc949" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0.0036; upper_lower: 0.0055; serum: HENV-32; upper: 0.0055; lower: 0.0036" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,199.4)" x2="0" y2="-0.3166666666666913" stroke="#edc949" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.0822; upper_lower: 1.1386; serum: HENV-103; upper: 1.1386; lower: 1.0822" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,19.633333333333326)" x2="0" y2="-9.40000000000001" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.0095; upper_lower: 1.0496; serum: HENV-103; upper: 1.0496; lower: 1.0095" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,31.75000000000001)" x2="0" y2="-6.683333333333373" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.0609; upper_lower: 1.0921; serum: HENV-103; upper: 1.0921; lower: 1.0609" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,23.183333333333334)" x2="0" y2="-5.200000000000028" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.689; upper_lower: 0.7783; serum: HENV-103; upper: 0.7783; lower: 0.689" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,85.16666666666669)" x2="0" y2="-14.883333333333368" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.1517; upper_lower: 0.1684; serum: HENV-103; upper: 0.1684; lower: 0.1517" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,174.71666666666667)" x2="0" y2="-2.7833333333333314" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0051; upper_lower: 0.0069; serum: HENV-103; upper: 0.0069; lower: 0.0051" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.15)" x2="0" y2="-0.30000000000001137" stroke="#e15759" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0.0004; upper_lower: 0.0014; serum: HENV-103; upper: 0.0014; lower: 0.0004" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,199.93333333333334)" x2="0" y2="-0.1666666666666572" stroke="#e15759" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.0345; upper_lower: 1.0702; serum: HENV-117; upper: 1.0702; lower: 1.0345" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,27.583333333333336)" x2="0" y2="-5.950000000000053" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 0.986; upper_lower: 1.0636; serum: HENV-117; upper: 1.0636; lower: 0.986" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,35.66666666666669)" x2="0" y2="-12.933333333333376" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 0.6177; upper_lower: 0.6847; serum: HENV-117; upper: 0.6847; lower: 0.6177" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,97.05)" x2="0" y2="-11.166666666666657" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.0188; upper_lower: 0.0268; serum: HENV-117; upper: 0.0268; lower: 0.0188" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,196.86666666666665)" x2="0" y2="-1.3333333333333144" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0; upper_lower: 0; serum: HENV-117; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,200)" x2="0" y2="0" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0; upper_lower: 0; serum: HENV-117; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,200)" x2="0" y2="0" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; serum: HENV-117; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#76b7b2" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.051; upper_lower: 1.098; serum: EFNB2-monomeric; upper: 1.098; lower: 1.051" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,24.83333333333333)" x2="0" y2="-7.833333333333357" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.1309; upper_lower: 1.1742; serum: EFNB2-monomeric; upper: 1.1742; lower: 1.1309" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,11.516666666666664)" x2="0" y2="-7.216666666666649" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.0181; upper_lower: 1.0444; serum: EFNB2-monomeric; upper: 1.0444; lower: 1.0181" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,30.31666666666666)" x2="0" y2="-4.38333333333334" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.6209; upper_lower: 0.6987; serum: EFNB2-monomeric; upper: 0.6987; lower: 0.6209" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,96.51666666666665)" x2="0" y2="-12.96666666666664" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.0903; upper_lower: 0.1069; serum: EFNB2-monomeric; upper: 0.1069; lower: 0.0903" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,184.95)" x2="0" y2="-2.7666666666666515" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0013; upper_lower: 0.0019; serum: EFNB2-monomeric; upper: 0.0019; lower: 0.0013" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.78333333333333)" x2="0" y2="-0.09999999999999432" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0; upper_lower: 0; serum: EFNB2-monomeric; upper: 0; lower: 0" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,200)" x2="0" y2="0" stroke="#4e79a7" opacity="1"/><line aria-label="concentration: 0.00061; Fraction Infectivity: 1.0805; upper_lower: 1.0817; serum: EFNB3-dimeric; upper: 1.0817; lower: 1.0805" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(47.119790100646,19.91666666666663)" x2="0" y2="-0.19999999999998153" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.00244; Fraction Infectivity: 1.1084; upper_lower: 1.1161; serum: EFNB3-dimeric; upper: 1.1161; lower: 1.1084" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(83.24338958032376,15.266666666666694)" x2="0" y2="-1.2833333333333918" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.00977; Fraction Infectivity: 1.1068; upper_lower: 1.1125; serum: EFNB3-dimeric; upper: 1.1125; lower: 1.1068" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(119.39367382312639,15.533333333333331)" x2="0" y2="-0.9500000000000064" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.03906; Fraction Infectivity: 0.8253; upper_lower: 0.8887; serum: EFNB3-dimeric; upper: 0.8887; lower: 0.8253" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(155.50393433711014,62.44999999999998)" x2="0" y2="-10.566666666666634" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.15625; Fraction Infectivity: 0.362; upper_lower: 0.3974; serum: EFNB3-dimeric; upper: 0.3974; lower: 0.362" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(191.62920156096675,139.66666666666666)" x2="0" y2="-5.899999999999977" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 0.625; Fraction Infectivity: 0.0048; upper_lower: 0.0055; serum: EFNB3-dimeric; upper: 0.0055; lower: 0.0048" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(227.75280104064453,199.2)" x2="0" y2="-0.11666666666667425" stroke="#f28e2c" opacity="1"/><line aria-label="concentration: 2.5; Fraction Infectivity: 0.0002; upper_lower: 0.0002; serum: EFNB3-dimeric; upper: 0.0002; lower: 0.0002" role="graphics-symbol" aria-roledescription="errorbar" transform="translate(263.87640052032225,199.96666666666667)" x2="0" y2="0" stroke="#f28e2c" opacity="1"/></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend titled 'Antibody' for fill color and stroke color with 8 values: EFNB2-monomeric, EFNB3-dimeric, HENV-103, HENV-117, HENV-26, ending with nAH1.3"><g transform="translate(318,0)"><path class="background" aria-hidden="true" d="M0,0h148v155h-148Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(5,24)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#4e79a7" stroke="#4e79a7" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">EFNB2-monomeric</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,16)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#f28e2c" stroke="#f28e2c" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">EFNB3-dimeric</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,32)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#e15759" stroke="#e15759" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-103</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,48)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#76b7b2" stroke="#76b7b2" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-117</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,64)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#59a14f" stroke="#59a14f" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-26</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,80)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#edc949" stroke="#edc949" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">HENV-32</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,96)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#af7aa1" stroke="#af7aa1" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">m102.4</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(0,112)"><path class="background" aria-hidden="true" d="M0,0h137.02734375v14h-137.02734375Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(7,7)" d="M5,0A5,5,0,1,1,-5,0A5,5,0,1,1,5,0" fill="#ff9da7" stroke="#ff9da7" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(18,11)" font-family="Helvetica" font-size="14px" fill="#000" opacity="1">nAH1.3</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-text role-legend-title" pointer-events="none"><text text-anchor="start" transform="translate(5,16)" font-family="Helvetica" font-size="14px" font-weight="bold" fill="#000" opacity="1">Antibody</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>